1. Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy. Issue 2 (9th January 2009) Authors: Liu, C-H; Liang, C-C; Liu, C-J; Tsai, H-B; Hung, P-H; Hsu, S-J; Chen, S-I; Lin, J-W; Lai, M-Y; Chen, J-H; Chen, P-J; Chen, D-S; Kao, J-H Journal: Gut Issue: Volume 58:Issue 2(2009) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study. Issue 4 (19th September 2007) Authors: Liu, C-H; Liang, C-C; Lin, J-W; Chen, S-I; Tsai, H-B; Chang, C-S; Hung, P-H; Kao, J-H; Liu, C-J; Lai, M-Y; Chen, J-H; Chen, P-J; Kao, J-H; Chen, D-S Journal: Gut Issue: Volume 57:Issue 4(2008) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗